Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
5 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.
6 days ago
Prevention of glucocorticoid-induced osteoporosis (GIOP) and postmenopausal osteoporosis (PMOP) remains inadequate in patients with rheumatoid arthritis (RA), as shown in a study that evaluated the implementation of the 2003 and 2014 French guidelines on the prevention and treatment of GIOP and the 2012 update of the French guidelines for the treatment of PMOP.

Low-fat dietary pattern may improve breast cancer survival

07 Oct 2017

Women who follow a low-fat dietary pattern appear to have reduced breast cancer mortality, according to data from the Earlier Women’s Health Initiative Dietary Modification trial.

The trial randomly assigned 48,835 postmenopausal women with normal mammograms and had no prior breast cancer to a dietary intervention with goals of reducing fat intake to 20 percent of energy and increasing consumption of fruits, vegetables and grains (n=19,541), or to a usual diet comparison (n=29,294).

A total of 1,764 incident breast cancers were reported during the 8.5-year dietary intervention. Fewer breast cancer-related deaths occurred in the low-fat diet group than in the usual diet group (27 vs 61 deaths; hazard ratio [HR], 0.67; 95 percent CI, 0.43 to 1.06), although the difference was not significant (p=0.08). On the other hand, the number of deaths after breast cancer significantly differed, in favour of the low-fat diet group (40 vs 94 deaths; HR, 0.65; 0.45 to 0.94; p=0.02).

During the 16.1-year follow-up, with 3,030 incident breast cancers, the number of deaths after breast cancer was also significantly lower in the low-fat vs usual diet group (234 vs 443 deaths; HR, 0.82; 0.70 to 0.96; p=0.01).

Participants who followed a low-fat dietary pattern particularly achieved a significant reduction in fat intake and body weight (p<0.001 for all).

Dietary intervention through a low-fat diet is believed to restore insulin sensitivity and reverse insulin's tumour-promoting effects, given that insulin resistance commonly results from obesity. Previous studies have shown that chronically increased concentrations of insulin may induce tumour growth and that insulin resistance may promote breast cancer development. [Am J Clin Nutr 2007;86:878S-881S]

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
5 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.
6 days ago
Prevention of glucocorticoid-induced osteoporosis (GIOP) and postmenopausal osteoporosis (PMOP) remains inadequate in patients with rheumatoid arthritis (RA), as shown in a study that evaluated the implementation of the 2003 and 2014 French guidelines on the prevention and treatment of GIOP and the 2012 update of the French guidelines for the treatment of PMOP.